Cargando…
Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms
In the hippocampal formation of Alzheimer’s disease (AD) patients, both focal and diffuse deposits of Aβ peptides appear in a subregion- and layer-specific manner. Recently, pyroglutamate (pGlu or pE)-modified Aβ peptides were identified as a highly pathogenic and seeding Aβ peptide species. Since t...
Autores principales: | Hartlage-Rübsamen, Maike, Morawski, Markus, Waniek, Alexander, Jäger, Carsten, Zeitschel, Ulrike, Koch, Birgit, Cynis, Holger, Schilling, Stephan, Schliebs, Reinhard, Demuth, Hans-Ulrich, Roßner, Steffen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098988/ https://www.ncbi.nlm.nih.gov/pubmed/21301857 http://dx.doi.org/10.1007/s00401-011-0806-2 |
Ejemplares similares
-
Distinct glutaminyl cyclase expression in Edinger–Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Aβ pathology in Alzheimer’s disease
por: Morawski, Markus, et al.
Publicado: (2010) -
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
por: Becker, Andreas, et al.
Publicado: (2013) -
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2015) -
Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model
por: Bluhm, Alexandra, et al.
Publicado: (2022) -
Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2018)